I am happy to discuss this issue with my colleagues. As they are aware, this has been my high priority for a number of years, given that I am the author with Representative Henry Waxman of the Drug Price Competition and Patent Term Restoration Act--or ``Hatch-Waxman''. The Schumer-Clinton bill, which I know has been introduced by Representative Waxman in the House, is an important contribution to this dialogue. I want to work to reach an acceptable compromise on an expedited basis, and it is clear to me it must be a bipartisan effort.
Orrin Hatch: “I am happy to discuss this issue with my colleagues. As they are aware, this has been my high priority for a number of…”
On the recordMay 2, 2007
Source
govinfo.govEditor's note · Context
Discussing the importance of bipartisan efforts in drug price competition legislation.
Share
More from Orrin Hatch
Sep 18, 2018
I know of no further debate on the bill. The PRESIDING OFFICER. Is there further debate? Hearing none, the bill having been read the third time, the question is, Shall the bill pass? The bill (H.R. 1551), as amended, was passed.
Nov 27, 2018
I am grateful to my colleagues and especially my colleague from Louisiana for his kind remarks on the floor of the U.S. Senate. It means so much to me. I want him to know that. I want the others to realize how much I appreciated their…
Sep 25, 2018
Many of us on the committee have already expressed our concerns about the administration's heavy reliance on tariffs.





